1. Home >
  2. M&A >
  3. Buyout (LBO, MBO, MBI) >
  4. United States >
  5. Utah >
  6. Catalyze Partners Acquires Axcend

M&A Deal Summary

Catalyze Partners Acquires Axcend

On July 22, 2024, private equity firm Catalyze Partners acquired machinery company Axcend

Acquisition Highlights
  • This is Catalyze Partners’ 1st transaction in the Machinery sector.
  • This is Catalyze Partners’ 4th transaction in the United States.
  • This is Catalyze Partners’ 1st transaction in Utah.

M&A Deal Summary
Date 2024-07-22
Target Axcend
Sector Machinery
Buyer(s) Catalyze Partners
Deal Type Buyout (LBO, MBO, MBI)

Target

Axcend

Provo, Utah, United States
Axcend provides compact, high-performance liquid chromatography (HPLC) systems and accessories. These solutions allow scientists to bring the lab to the sample and HPLC Anywhere by providing dramatic improvements in portability, ease of operation, and rapid and convenient deployment, all with significantly reduced operating costs and solvent usage. Axcend is based in Provo, Utah.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Catalyze Partners

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 2014
Size Small
Type Sector Agnostic
DESCRIPTION

Catalyze Partners is an investment firm that acquires technologies from large corporations and looks to transform them into high-growth standalone businesses. The Firm will consider opportunities throughout North America and Europe. Catalyze Partners was formed in 2014 and is based in Dallas, Texas.

DEAL STATS #
Overall 4 of 4
Sector: Machinery M&A 1 of 1
Type: Buyout (LBO, MBO, MBI) M&A Deals 4 of 4
State: Utah M&A 1 of 1
Country: United States M&A 4 of 4
Year: 2024 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-01-01 Almaden Genomics

Dallas, Texas, United States

Almaden Genomics offers g.nome®, a cloud-native SaaS platform that accelerates genomic research and biotech development, and enables progress toward the full potential of precision medicine. Almaden Genomics is based in Dallas, Texas.

Buy -
Mergr

Solution for

Product

Company

Legal